Sorry, you need to enable JavaScript to visit this website.
angela_hwang_300X170.jpg

Angela Hwang

Chief Commercial Officer, President, Global Biopharmaceuticals Business

Angela Hwang is a member of Pfizer’s Executive Team and the Chief Commercial Officer and President of Pfizer’s Global Biopharmaceuticals Business, which is the commercial organization of Pfizer. Her organization of 26,000 colleagues across 125 countries is responsible for bringing over 600 innovative medicines and products to patients. In 2021, more than 1.4 billion people benefited from our medicines or vaccines to improve their health and, in some cases, save their lives. Altogether, Pfizer Biopharma generated almost $82 billion in 2021 revenues.

Pfizer’s Biopharma business encompasses transformational medicines that address major global health priorities including cancer, COVID, infectious diseases, inflammation & immunology, preventative care with vaccines, primary care, and rare disease. She is also responsible for the advancement of innovative access partnerships with payers and governments around the world.

Angela has been with Pfizer for 26 years, working across all geographies and therapeutic areas. She is motivated by the common purpose that all Pfizer colleagues share, to bring breakthroughs to patients, regardless of where they are in the world. Her childhood as an Asian girl growing up in apartheid South Africa, defined her worldview and underscored the importance of equity in everything she does today.

Angela is a member of the Board of Directors of UPS, the global leader in supply chain logistics and package delivery, EFPIA (European Federation of Pharmaceutical Industries and Associations), as well as the Pfizer Foundation, a charitable organization that addresses global health challenges. In 2019, she was named in Crain’s Notable Women in Healthcare list. In 2020 she was ranked #16 in Fortune’s Top 50 Most Powerful Women list, and in 2021 she ranked #11, as well as being recognized in Forbes’ inaugural CEO Next list. She has also been honored as one of Modern Healthcare’s Top 25 Women Leaders, and as an A100 Honoree, which celebrates the 100 most impactful AAPI leaders of the past year. She received the President’s AwardTM from the National Diversity Council in 2021, for her efforts to champion diversity, equity, and inclusion. In 2022, Angela was also named the 39th Cornell University Robert S. Hatfield Economic Fellow.

Having always been curious about transformation and the art of the possible, in 2019, Angela launched Diverse Perspectives, a podcast series where she hosts global thought leaders pioneering change across a variety of industries. 

Angela received her Bachelor of Science in Microbiology and Biochemistry from the University of Cape Town and her MBA from Cornell University, where she remains a Member of the Advisory Council of the SC Johnson Graduate School of Business. She is a wife and proud mom to a teenage son and daughter, and a strong advocate for women’s leadership and sustainable global health equity.

To learn more, follow Angela on LinkedIn and on Instagram using @angelahwangpfizer.

ab_headshot_2021_300x170.jpg
Dr. Albert Bourla

Chief Executive Officer and Chairman

Bill Carapezzi
Bill Carapezzi

Executive Vice President, Global Business Services and Transformation

dave_denton_300x170.jpg
Dave Denton

Chief Financial Officer and Executive Vice President

Media Name: mikael_dolsten300x170_2019_v3.jpg
Mikael Dolsten, M.D., Ph.D.

Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.

Media Name: lidia_fonseca300x170.jpg
Lidia Fonseca

Chief Digital and Technology Officer, Executive Vice President

Media Name: rady-johnson300x170px.jpg
Rady Johnson

Chief Compliance, Quality and Risk Officer, Executive Vice President

Media Name: doug_profile_bio_2019_300x170.jpg
Doug Lankler

General Counsel, Executive Vice President

Aamir Malik
Aamir Malik

Chief Business Innovation Officer, Executive Vice President

MikeMcDermott_300x170.jpg
Mike McDermott

Chief Global Supply Officer, Executive Vice President

william_pao_2_300x170.jpg
William Pao, M.D., Ph.D.

Chief Development Officer, Executive Vice President

payal_2021_300x170.jpg
Payal Sahni Becher

Chief People Experience Officer, Executive Vice President

Sally-Susman-2022_300x170_2.jpg
Sally Susman

Chief Corporate Affairs Officer, Executive Vice President

angela_hwang_300X170.jpg

Angela Hwang

Chief Commercial Officer, President, Global Biopharmaceuticals Business

Angela Hwang is a member of Pfizer’s Executive Team and the Chief Commercial Officer and President of Pfizer’s Global Biopharmaceuticals Business, which is the commercial organization of Pfizer. Her organization of 26,000 colleagues across 125 countries is responsible for bringing over 600 innovative medicines and products to patients. In 2021, more than 1.4 billion people benefited from our medicines or vaccines to improve their health and, in some cases, save their lives. Altogether, Pfizer Biopharma generated almost $82 billion in 2021 revenues.

Pfizer’s Biopharma business encompasses transformational medicines that address major global health priorities including cancer, COVID, infectious diseases, inflammation & immunology, preventative care with vaccines, primary care, and rare disease. She is also responsible for the advancement of innovative access partnerships with payers and governments around the world.

Angela has been with Pfizer for 26 years, working across all geographies and therapeutic areas. She is motivated by the common purpose that all Pfizer colleagues share, to bring breakthroughs to patients, regardless of where they are in the world. Her childhood as an Asian girl growing up in apartheid South Africa, defined her worldview and underscored the importance of equity in everything she does today.

Angela is a member of the Board of Directors of UPS, the global leader in supply chain logistics and package delivery, EFPIA (European Federation of Pharmaceutical Industries and Associations), as well as the Pfizer Foundation, a charitable organization that addresses global health challenges. In 2019, she was named in Crain’s Notable Women in Healthcare list. In 2020 she was ranked #16 in Fortune’s Top 50 Most Powerful Women list, and in 2021 she ranked #11, as well as being recognized in Forbes’ inaugural CEO Next list. She has also been honored as one of Modern Healthcare’s Top 25 Women Leaders, and as an A100 Honoree, which celebrates the 100 most impactful AAPI leaders of the past year. She received the President’s AwardTM from the National Diversity Council in 2021, for her efforts to champion diversity, equity, and inclusion. In 2022, Angela was also named the 39th Cornell University Robert S. Hatfield Economic Fellow.

Having always been curious about transformation and the art of the possible, in 2019, Angela launched Diverse Perspectives, a podcast series where she hosts global thought leaders pioneering change across a variety of industries. 

Angela received her Bachelor of Science in Microbiology and Biochemistry from the University of Cape Town and her MBA from Cornell University, where she remains a Member of the Advisory Council of the SC Johnson Graduate School of Business. She is a wife and proud mom to a teenage son and daughter, and a strong advocate for women’s leadership and sustainable global health equity.

To learn more, follow Angela on LinkedIn and on Instagram using @angelahwangpfizer.

ab_headshot_2021_300x170.jpg
Dr. Albert Bourla

Chief Executive Officer and Chairman

Bill Carapezzi
Bill Carapezzi

Executive Vice President, Global Business Services and Transformation

dave_denton_300x170.jpg
Dave Denton

Chief Financial Officer and Executive Vice President

Media Name: mikael_dolsten300x170_2019_v3.jpg
Mikael Dolsten, M.D., Ph.D.

Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.

Media Name: lidia_fonseca300x170.jpg
Lidia Fonseca

Chief Digital and Technology Officer, Executive Vice President

Media Name: rady-johnson300x170px.jpg
Rady Johnson

Chief Compliance, Quality and Risk Officer, Executive Vice President

Media Name: doug_profile_bio_2019_300x170.jpg
Doug Lankler

General Counsel, Executive Vice President

Aamir Malik
Aamir Malik

Chief Business Innovation Officer, Executive Vice President

MikeMcDermott_300x170.jpg
Mike McDermott

Chief Global Supply Officer, Executive Vice President

william_pao_2_300x170.jpg
William Pao, M.D., Ph.D.

Chief Development Officer, Executive Vice President

payal_2021_300x170.jpg
Payal Sahni Becher

Chief People Experience Officer, Executive Vice President

Sally-Susman-2022_300x170_2.jpg
Sally Susman

Chief Corporate Affairs Officer, Executive Vice President